首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8137篇
  免费   777篇
  国内免费   399篇
医药卫生   9313篇
  2024年   11篇
  2023年   100篇
  2022年   177篇
  2021年   363篇
  2020年   240篇
  2019年   276篇
  2018年   316篇
  2017年   262篇
  2016年   263篇
  2015年   358篇
  2014年   401篇
  2013年   446篇
  2012年   550篇
  2011年   613篇
  2010年   369篇
  2009年   274篇
  2008年   432篇
  2007年   451篇
  2006年   484篇
  2005年   436篇
  2004年   278篇
  2003年   294篇
  2002年   212篇
  2001年   181篇
  2000年   175篇
  1999年   195篇
  1998年   134篇
  1997年   118篇
  1996年   87篇
  1995年   80篇
  1994年   68篇
  1993年   39篇
  1992年   100篇
  1991年   59篇
  1990年   68篇
  1989年   34篇
  1988年   53篇
  1987年   47篇
  1986年   39篇
  1985年   35篇
  1984年   20篇
  1983年   17篇
  1982年   13篇
  1981年   20篇
  1980年   11篇
  1979年   21篇
  1976年   15篇
  1973年   9篇
  1969年   7篇
  1965年   6篇
排序方式: 共有9313条查询结果,搜索用时 31 毫秒
21.
木贼对大白鼠实验性高脂血症的影响及急性毒性实验研究   总被引:6,自引:0,他引:6  
实验结果表明,木贼高,低剂量组,安妥明组均有显著阻止高脂饲料升高大白鼠血清总胆固醇、甘油三酯作用,表明木贼对大白鼠实验性高脂血症有防治作用。急性毒性实验表明其毒性很低。  相似文献   
22.
21世纪中医学的发展,面临着理顺民族性表述方式与国际性科学内涵关系的问题,因此必须辩证地把握结构与机能、实证科学手段与人文精神、过程与结果之间的谐调统一,这样既符合中医学术体系特征,又能与当代生命科学研究保持一致。  相似文献   
23.
Summary Fifty-five patients with metastatic non-small cell lung cancer (NSCLC) were entered into this phase II randomized study for evaluating three new agents: gallium nitrate, amonafide and teniposide. The patients had to have ECOG performance status 0 or 1, no prior chemotherapy, and adequate hematological, hepatic and renal functions. Forty-seven patients were eligible and evaluable. Fourteen were randomized to receive gallium nitrate, 18 to amonafide and 15 to teniposide. Seventy-four percent of eligible patients were male. The majority of patients (89%) had an ECOG performance status 1. ECOG grade 4 toxicity occurred twice in patients on gallium nitrate, seven times on amonafide and 18 times on teniposide. The cause of death was attributed to amonafide in one patient (from sepsis) and to teniposide in two patients (due to infection and leukopenia). There was no objective response in all the patients entered. The overall survival times ranged from 2 weeks to 156 weeks with a median of 23 weeks. There were no survival differences among the three treatment arms. We conclude that gallium nitrate, amonafide and teniposide are inactive in metastatic NSCLC and do not warrant any further testing in this disease.The contents of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute.  相似文献   
24.
应用肝素雾化治疗小儿哮喘性疾病(包括以喘为主的支气管肺炎)16例,其咳喘症状消失和肺部体征消失时间校对照组快,总显效率高。文中还就7例肝素雾化治疗前后血气结果对照,进一步阐述肝素雾化有利于改善通气功能,促进二氧化碳排出和炎症吸收,从而解除支气管痉挛的机理。具有疗效显著,安全可靠,无任何副作用的特点,值得临床推广应用。  相似文献   
25.
Oral cancer progression and c-erbB-2/neu proto-oncogene expression.   总被引:2,自引:0,他引:2  
L Hou  D Shi  S M Tu  H Z Zhang  M C Hung  D Ling 《Cancer letters》1992,65(3):215-220
Monoclonal antibody PAb3 to c-erbB-2/neu protein was utilized in the immunoperoxidase staining of 86 human specimens from oral mucosa. These tissue specimens represented a spectrum from 7 normal to 9 simple hyperplasia, 15 mild dysplasia, 14 moderate dysplasia, 20 severe dysplasia and 21 squamous cell carcinoma. Our study indicated that as the cells acquire a more malignant phenotype, there was a progressive increase in neu expression. It also suggested that neu may be involved in the development of oral cancers and that its evaluation in the early stages may assist in the diagnosis and management of oral cancers.  相似文献   
26.
本文采用Iodogen法将鼠抗人胃癌单克隆抗体RSF9(IgM)予以131I标记,研究RSF9在荷人胃癌裸鼠中的定位和显像能力。结果表明,RSF9在体内能特异性地与肿瘤组织结合,T/NT比值随时间延长逐渐升高,96hT/NT比值均大于2.5,瘤/血比值为2.69,肿瘤定位指数达5.18,SPECT得到清晰的肿瘤图像。RSF9具有良好的体内导向定位能力。IgM型单抗也可用于肿瘤显像。  相似文献   
27.
Increased expression of certain glutathione S-transferase (GST) isoenzymes has frequently been associated with the development of resistance to alkylating agents and other classes of antineoplastic drugs in drug-selected cell lines. The question arises whether this phenomenon is causal or is a stress-induced response associated with drug resistance in these cell lines. We have constructed mammalian expression vectors containing the human GST mu and GST alpha 2 (Ha2) cDNAs and stably transfected them into the human breast cancer cell line MCF-7. Whereas the parental and pSV2neo-transfected cell lines display low GST activity, three individual transfected clones were identified in each group that expressed either GST mu or GST alpha 2. The range of GST activities was similar to those observed in cells selected for anticancer drug resistance. The GST mu specific activities were 56, 150, and 340 mlU/mg, compared with 10 mlU/mg of endogenous GST mu in control lines. Specific activities in GST alpha 2-transfected clones were 17, 28, and 52 mlU/mg, compared with no detectable alpha class GST in control lines. These clonal lines and the parental and pSV2neo-transfected control lines were tested for sensitivity to antineoplastic agents and other cytotoxic compounds. The clones with the highest activity in each group were 1.7-fold (GST alpha 2) to 2.1-fold (GST mu) resistant to the toxic effects of ethacrynic acid, a known substrate for GSTs. However, the GST-transfected cell lines were not resistant to doxorubicin, L-phenylalanine mustard, bis(2-chloroethyl)-1-nitrosourea, cisplatin, chlorambucil, or the GST substrates 1-chloro-2,4-dinitrobenzene or tert-butyl hydroperoxide. Thus, although L-phenylalanine mustard, bis(2-chloroethyl)-1-nitrosourea, chlorambucil, tert-butyl hydroperoxide, and 1-chloro-2,4-dinitrobenzene are known to be metabolized by glutathione-dependent GST-catalyzed reactions, there was no protection against any of these agents in MCF-7 cell lines overexpressing GST mu or GST alpha 2. We conclude that, at the levels of GST obtained in this transfection model system, overexpression of GST mu or GST alpha 2 is not by itself sufficient to confer resistance to these anticancer agents. These studies do not exclude the possibility that GST may be a marker of drug resistance or that other gene products not expressed in MCF-7 cells might cooperate with GST to confer drug resistance.  相似文献   
28.
1. Pharmacokinetics and pharmacodynamics of R- and S-verapamil and R- and S-norverapamil were studied at steady state following administration of 180 mg verapamil delivered by a controlled-release gastrointestinal therapeutic system (COER-verapamil). 2. Of the 30 young (19 to 43 years) and 30 elderly subjects (65 to 80 years) enrolled, approximately half of each age group were women; all subjects were healthy and none were smokers. 3. Mean R- and S-verapamil and R- and S-norverapamil Cmax, Cmin, and AUC values for elderly subjects were 1.2 to 2.2 times greater than those for young subjects; these differences were statistically significant at P < 0.05. Median tmax values for young and elderly subjects were not significantly different for any enantiomer. The mean half-life values of R- and S-verapamil for elderly subjects were approximately 20 h compared with approximately 13 h for young subjects, respectively. The mean half-life values of R- and S-norverapamil for elderly subjects were approximately 31 h and 20 h, respectively, compared with approximately 19 h and 21 h for young subjects, respectively. 4. In both age groups, the mean plasma verapamil concentrations of each enantiomer were higher for women than for men at all time points. 5. Mean arterial pressure (MAP) had a significant correlation to R- (r2 = 0.86) and S-verapamil (r2 = 0.87) concentration values that was not influenced by either gender or age of the patient. Change in PR-interval also had a significant correlation to R- and S-verapamil concentration values. However, the sensitivity of the response to changes in R- and S-verapamil concentration values in elderly subjects was about 1/5 of that in younger subjects.  相似文献   
29.
反相高效液相色谱法测定牛黄类中成药中胆汁酸的含量   总被引:7,自引:0,他引:7  
倪坤仪  王建  陈健  郁建  屠树滋 《药学学报》1994,29(8):624-633
反相高效液相色谱法测定牛黄类中成药中胆汁酸的含量倪坤仪,王建,陈健,郁建,屠树滋(中国药科大学210009)含牛黄的中成药种类很多,在医疗中具有广泛的用途。中药牛黄中主要成分为胆汁酸和胆红素。本文主要研究用HPLC法测定牛黄以及含牛黄中成药中胆汁酸的...  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号